MENU
+Compare
AGIO
Stock ticker: NASDAQ
AS OF
May 8 closing price
Price
$28.04
Change
-$0.18 (-0.64%)
Capitalization
1.62B

AGIO Agios Pharmaceuticals Forecast, Technical & Fundamental Analysis

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology... Show more

Industry: #Biotechnology
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AGIO with price predictions
May 07, 2025

AGIO's RSI Indicator ascending out of oversold territory

The RSI Oscillator for AGIO moved out of oversold territory on April 09, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In of the 24 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for AGIO just turned positive on April 15, 2025. Looking at past instances where AGIO's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AGIO advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 70 cases where AGIO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on May 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AGIO as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

AGIO moved below its 50-day moving average on May 02, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AGIO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AGIO broke above its upper Bollinger Band on May 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AGIO entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.118) is normal, around the industry mean (14.238). P/E Ratio (2.454) is within average values for comparable stocks, (62.770). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.866). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (44.444) is also within normal values, averaging (252.967).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AGIO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AGIO is expected to report earnings to rise 20.00% to -186 cents per share on July 31

Agios Pharmaceuticals AGIO Stock Earnings Reports
Q2'25
Est.
$-1.86
Q1'25
Beat
by $0.23
Q4'24
Beat
by $0.24
Q3'24
Beat
by $1.00
Q2'24
Missed
by $0.09
The last earnings report on May 01 showed earnings per share of -154 cents, beating the estimate of -177 cents. With 547.58K shares outstanding, the current market capitalization sits at 1.62B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
88 Sidney Street
Phone
+1 617 649-8600
Employees
386
Web
https://www.agios.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FANIX43.34N/A
N/A
Fidelity Advisor Energy I
TGRIX13.20N/A
N/A
American Century International Gr I
TAREX23.41N/A
N/A
Third Avenue Real Estate Value Instl
ISCSX15.29N/A
N/A
VY® Columbia Contrarian Core S
APGZX104.46N/A
N/A
AB Large Cap Growth Z

AGIO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with INSM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then INSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
-0.64%
INSM - AGIO
46%
Loosely correlated
-3.88%
AXON - AGIO
45%
Loosely correlated
+14.13%
OLMA - AGIO
45%
Loosely correlated
+0.86%
CRNX - AGIO
43%
Loosely correlated
+4.17%
RVMD - AGIO
42%
Loosely correlated
+11.29%
More